CD8A and allergic disease: Thus, it is now somewhat less surprising to find that treatment with Tregitopes can suppress humoral immune responses to co-administered antigens, induce adaptive T cells (aTreg or iTreg), suppress CD8+T cell responses in an antigen-specific manner, suppress Th17 cells, and suppress reactive airway responses and IgE in an OVA model of allergy.